|09/27/17||Pacira Pharmaceuticals CEO to Testify at White House Opioid Crisis Commission Meeting|
|PARSIPPANY, N.J., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that Dave Stack, chairman and chief executive officer, will testify this afternoon before President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis. The Commission, led by New Jersey Governor Chris Christie, was created to study ways to combat and treat drug abuse, addiction and the opioid crisis.
The meeting, which will be held in Washington, D.C. today from ... |
|09/26/17||New Research: Overprescribing of Postsurgical Opioids Poses a Serious Threat to Patients and their Communities; Women Undergoing Surgery are at Greatest Risk|
|Patients receive an average of 85 pills following surgery; overprescribing leads to 3.3 billion unused postsurgical opioids every year
An Analysis of the Impact of Opioid Overprescribing in America
Middle-aged and Generation X women have highest rates of p... |
|09/20/17||Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference|
|PARSIPPANY, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that members of its management team are scheduled to present at the 2017 Cantor Fitzgerald Global Healthcare Conference at 10:20 AM ET on Tuesday, September 26, 2017 in New York City.
A live audio webcast of the Pacira presentation can be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com. A replay of the webcast will be archiv... |
|09/13/17||Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons Join Together in a Program to Reduce Opioid Exposure for Patients Undergoing Wisdom Tooth Extraction|
|The national program aims to reduce the volume of opioids prescribed following wisdom tooth extraction by 50 percent
PARSIPPANY, N.J., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), today announced a collaboration with Aetna, one of the nation’s leading diversified health care benefits companies, with the support of the American Association of Oral and Maxillofacial Surgeons (AAOMS), on a national program aimed at reducing the number of opioid tablets prescribe... |